_in_Mizushima,_Japan_256_384.jpg)
News | February 29, 2024
Asahi Kasei offers pharmaceutical excipient Ceolus with nitrite concentration of 0.1 ppm or less
Contributing to lower risk of potentially carcinogenic nitrosamine impurities in pharmaceuticals
Contributing to lower risk of potentially carcinogenic nitrosamine impurities in pharmaceuticals
Pfizer INDovation program partners with NIPER Ahmedabad to incubate healthcare startups
VELSIPITY is the first and only oral advanced ulcerative colitis therapy approved for use in patients 16 years of age or older in the EU
Commercialization of rPEG lipids designed to improve immunogenicity profile for nucleic acid delivery
Pelabresib recently met its primary endpoint of spleen volume reduction and demonstrated favorable trends in symptom improvement
Global TB incidence saw a reduction of 8.7% while in India we were able to demonstrate a reduction of 16%, almost double the pace
1,000 Ph.D. students will be enrolled in the next five years to drive innovation in the critical healthcare sector
Cipla has reported total income of Rs. 6,788.44 crores during the period ended December 31, 2023
GC1130A has previously achieved notable milestones by securing both RPDD and ODD from the U.S. FDA in January 2023
Inducts advanced AI-Powered 24x7 remote patient monitoring system
Subscribe To Our Newsletter & Stay Updated
